Palantir beat Wall Street's third-quarter estimates after the bell on Monday, with adjusted earnings of 44 cents per share versus 41 cents expected and revenue of $2.31 billion versus $2.18 billion. U.S. commercial revenue rose 148% to $984 million, topping U.S. government revenue of $953 million (up 96%) for the first time. Net income more than doubled to $1.13 billion. Palantir raised its full-year U.S. commercial revenue outlook to “in excess of” $3.56 billion from $3.42 billion, and projects about $2.65 billion in fourth-quarter revenue and about $8.53 billion for full-year 2026.
Summary written by Upside AI from the original article. Read the source for full details.
Keywords
Palantirearningsartificial intelligencesoftware
Open a keyword to see other news on the same topic.
Related tickers and likely impact
NVDA
▲ Likely positiveNvidia
Relevance: low
| Market | US stocks |
|---|---|
| Sector | Information Technology |
| Industry | Semiconductors |
| Market cap | $5.1T |
| Close on 11/02/2026 | 202.06 |
| Change that session | -1.26% |
QQQ
▲ Likely positiveInvesco QQQ Trust
Relevance: low
| Market | US stocks |
|---|---|
| Sector | ETF |
| Close on 11/02/2026 | 681.13 |
| Change that session | -1.36% |
Impact is scored by AI from the headline and may be wrong. It is not investment advice.
Related news
- Palantir Grows Revenue 96% as New Deals Slow: Rapid Earnings Reaction
Palantir (PLTR) grew third-quarter revenue 96% to about $2.31 billion and raised its full-year revenue outlook again to about $8.53 billion, or 91% growth. U.S. commercial revenue rose 148% to $984 million and surpassed U.S. government revenue for the first time, which was $953 million. GAAP operating margin reached 47%, up from 33% a year earlier, as operating expenses grew about 46% while revenue nearly doubled. The soft spot is new business: total contract value closed was $2.92 billion, up just 6% year over year. The article says the key metric to watch is U.S. commercial remaining deal value, which rose 4% from last quarter while U.S. commercial revenue rose 29%; if this does not improve, the current growth rate will be hard to sustain.
- Palantir earnings reveal a major AI turning point
In the third quarter, Palantir's U.S. commercial business brought in more money than its U.S. government segment. This was a key point in the company's earnings report.
- Palantir Technologies vs. Figma: Comparing Revenue Growth Trends
This comparison looks at revenue over the last eight quarters for Figma (FIG) and Palantir Technologies (PLTR), using data as of Oct. 22, 2026. Figma, a browser-based design platform, recently launched several AI design features and disclosed that its CEO voluntarily forfeited $46 million in stock awards. Its second-quarter sales of $370.1 million rose 48% year over year, partly due to AI credit monetization, with Q2 being the first full quarter of that revenue stream. Palantir's revenue is considerably larger and has increased every quarter, with the company forecasting third-quarter revenue of around $2.2 billion; it has also secured a U.S. Army ground station production contract and a collaboration with NVIDIA. Figma is scheduled to report third-quarter earnings on Nov. 4.
- Palantir Guided for $2.16 Billion in Revenue for Q3. Its Last 2 Quarters Suggest We Should Expect More.
Palantir (PLTR) guided for third-quarter revenue of $2.160 billion to $2.164 billion, but the author considers that forecast conservative given its first-half results. In the first and second quarters, revenue beat the midpoint of guidance by about 6.4% and 7.5%, with second-quarter revenue reaching $1.935 billion, up 93% year over year. U.S. commercial revenue rose 149% to $764 million in the second quarter, and total contract value reached $3.37 billion. If sequential growth matches the 19% of the second quarter, third-quarter revenue would be about $2.3 billion, and the author will be watching whether it exceeds that level.
- Palantir Technologies (PLTR) Deepens Sovereign AI Deployments Across Sensitive Industries
Palantir Technologies (PLTR) announced a new wave of sovereign AI deployments with partners including L3Harris, McCarthy, NVIDIA, Ondas, and Tampa General Hospital. The collaborations span sensitive sectors such as defense, advanced manufacturing, construction, and healthcare, focusing on real-world AI workflows and data control. Clients use Palantir's platforms to fine-tune models, keep control over their data, and pursue operational efficiency. The article argues the moves reinforce the company's software moat but also heighten reliance on large U.S. government and defense contracts and a customer base skewed heavily toward the U.S. It suggests tracking upcoming earnings updates through late 2026 for disclosures on total contract value and how much demand comes from outside the U.S.
- Prediction: This Will Be Palantir's Stock Price by the End of 2027
Palantir's shares are up almost 700% over five years, but its rally has slowed over the past 12 months. Demand for its AI-powered data analytics has been strong: second-quarter revenue rose 93% year over year to $1.94 billion, with U.S. commercial clients up 149%. The company does not build its own AI models and works with third-party APIs, while its work with government clients such as the CIA, NATO and the Department of Defense may support its security reputation. The article cites a forward P/E of 89 versus the S&P 500 average of 19 as a key concern, along with political risks such as its work with ICE. Assuming a return near the S&P 500's roughly 10% annual average, it estimates a price around $216 by end-2027 from $197 on Oct. 29, and suggests investors may wait for a cheaper price before taking a large position.
Related markets
Latest news
- Stock Market Today, Nov. 2: Amazon Rallies on Phillip Securities Buy Upgrade and $330 Target
Amazon (AMZN) closed at $245.63, up 2.20%, after Phillip Securities upgraded the stock to “buy” and raised its price target by $10 to $330. Analyst Helena Wang raised her rating and fiscal 2027 revenue estimates, citing strong cloud demand: AWS sales jumped 39% year over year to $46 billion, the fastest growth in nearly five years, and operating income rose 61%. Trading volume reached 57.7 million shares, about 51% above the three-month average of 38.3 million. The stock had slid after last week's earnings report, where heavy AI-related capital spending and cash outflows triggered an initial negative reaction. Broader markets declined, with the S&P 500 down 0.50% to 7,542 and the Nasdaq Composite down 1.07% to 25,164.
- Wesdome Expands High-Grade Zones at Eagle River, Highlighting Growth Potential near Existing Infrastructure
Wesdome Gold Mines (TSX: WDO) reported drilling results from its Eagle River mine near Wawa, Ontario. A hole in the western extension of the 800 Zone intersected 8.3 g/t gold over 10.6 metres, while mineralization was found more than 200 metres below the current zone model. A 500 Zone hole returned 96.2 g/t gold over 2.2 metres (uncapped), and the 700 Zone showed 20.2 g/t gold over 5.7 metres, outlining an interpreted 200 x 100 metre growth area near existing infrastructure. The 2026 near-mine program comprised 21 underground drill holes and one deep surface hole, totalling about 8,000 metres, with four underground exploration drills continuing through 2027. The company said shallower zones near infrastructure could reduce access development and transport distances, offering more options for where and when to mine.
- Apple Posts Fiscal Q4 Beat On Strong iPhone, Services Sales
Apple beat Wall Street's targets for its fiscal fourth quarter, with strong iPhone and services sales. Its stock was flat in extended trading after the report was released late Monday.
- Why Indivior Pharmaceuticals Stock Topped the Market Today
On Monday, Indivior Pharmaceuticals (INDV) shares rose more than 3% on their final day as a standalone company, after its merger with Supernus Pharmaceuticals (SUPN) closed. The combined business describes itself as a leading diversified central nervous system (CNS) biopharmaceutical company and will operate under the Supernus name and ticker. Under the deal terms, Supernus shareholders receive just over 1.5 Indivior shares for each Supernus share they own, while Indivior shareholders receive a one-time special cash dividend of $1 billion before the merger closed. Indivior shareholders are expected to hold about 56.5% of the combined business, and the companies aim to reach $125 million in annual cost synergies.
- Apple Sales Rise 12%; Tariff Refunds Pad EPS: Rapid Earnings Reaction
Apple posted record September-quarter revenue of $114.5 billion for fiscal 2026's fourth quarter, up 12% year over year, while shares were roughly flat after hours. Tariff refunds, a one-time item, added about 1 percentage point to gross margin and $0.05 to EPS; without them, EPS growth would be about 11%, slightly below sales growth. Diluted EPS rose 14% to $2.10, gross margin reached 47.9%, and operating cash flow was $28 billion, with $28 billion returned to shareholders. The holiday quarter is the next test, as Apple launches the iPhone Duo, new home hardware, touch on the Mac and a rebuilt Siri; high early production costs could pressure margins. The article suggests watching gross margin excluding refunds, with holding near 47% indicating the new lineup is not eating into profit.
- Elizabeth Warren Wants to Break Up UnitedHealth, and One Day Later a Nonprofit Called It Undervalued
Senator Elizabeth Warren criticized UnitedHealth Group's (UNH) $3.3 billion purchase of Amedisys, arguing it gives the company more power to raise costs and deny care, and called for breaking up the company. On November 2, 2026, the nonprofit BetterInvesting named UnitedHealth its “Undervalued Stock” in its January–February 2027 issue, stating the list is for educational purposes and is not an endorsement by NAIC/BetterInvesting. UnitedHealth shares traded at $399.90, down 1.74% on the day and 4.35% over the week, though still up 23.51% this year. Third-quarter adjusted EPS came in at $4.69, above the $4.15 estimate, and the company raised its 2026 adjusted EPS guidance to at least $20.50. Medicare Advantage membership has fallen by 935,000 since year-end 2025, and Warren co-sponsored the Patients Before Monopolies Act (S. 4509).
Get the briefing on Telegram or Zalo
Join the Upside Telegram channel or Zalo group for the Vietnam stocks and gold briefing at 8:00 and 19:00 (Vietnam time) on trading days, plus a weekly wrap on Saturday morning.